Patient-reported outcomes of adalimumab, phototherapy, and placebo in the Vascular Inflammation in Psoriasis Trial: A randomized controlled study Article

sustainable development goals

authors

publication date

  • 2019

webpage

published in

keywords

  • DLQI
  • EQ5D
  • adalimumab
  • patient-reported outcomes
  • phototherapy
  • psoriasis
  • randomized controlled trials

PubMed Central ID

  • PMC6746579

start page

  • 923

end page

  • 930

volume

  • 81

issue

  • 4